Long-term treatment of leiomyomas with gestrinone
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 51 (6) , 939-946
- https://doi.org/10.1016/s0015-0282(16)60722-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteriFertility and Sterility, 1988
- Treatment of endometriosis by vaginal administration of gestrinoneFertility and Sterility, 1988
- Endometriosis Therapy with Gestrinone by Oral, Vaginal or Parenteral AdministrationPublished by S. Karger AG ,1987
- Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesteroneAmerican Journal of Obstetrics and Gynecology, 1986
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.BMJ, 1984
- Treatment of fibrocystic disease of the breast with gestrinone, a new trienic synthetic steroid with anti-estrogen, anti-progesterone propertiesInternational Journal of Gynecology & Obstetrics, 1984
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983
- Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesteroneAmerican Journal of Obstetrics and Gynecology, 1982